FDA advisory panel voices persistent safety concerns.
Finkelstein
Joel B
JB
D026683:Advisory Committees; D017277:Drug Approval / Q000458:organization & administration*; D006801:Humans; D011057:Politics; D011358:Product Surveillance, Postmarketing / Q000592:standards; D011640:Public Policy; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration